Cabaletta Bio (CABA) Gains from Investment Securities (2018 - 2025)

Cabaletta Bio's Gains from Investment Securities history runs 8 years deep, the most recent figure standing at -$11.4 million for Q4 2025.

• In Q4 2025, Gains from Investment Securities fell 203.93% year-over-year to -$11.4 million; the TTM figure through Dec 2025 stood at -$431000.0 (down 101.78% YoY), while the FY2025 annual figure was $3.5 million, down 69.11% from the prior year.
• Gains from Investment Securities was -$11.4 million for Q4 2025 at Cabaletta Bio, down from $3.1 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $13.7 million in Q4 2022 to a low of -$11.4 million in Q4 2025.
• Historically, Gains from Investment Securities has averaged $2.4 million across 5 years, with a median of $2.0 million in 2021.
• The sharpest annual moves came in 2021 and 2022: Gains from Investment Securities sank 230.65% in 2021, then surged 17062.96% in 2022.
• A 5-year view of Gains from Investment Securities shows it stood at -$81000.0 in 2021, then soared by 17062.96% to $13.7 million in 2022, then slumped by 104.03% to -$554000.0 in 2023, then jumped by 2078.88% to $11.0 million in 2024, then plunged by 203.93% to -$11.4 million in 2025.
• The last three Gains from Investment Securities figures came in at -$11.4 million (Q4 2025), $3.1 million (Q3 2025), and $84325.0 (Q2 2025), per Business Quant data.